Characterization of Alzheimer’s tau biomarker discordance using plasma, CSF, and PET

BACKGROUND: We aimed to investigate the tau biomarker discrepancies of Alzheimer’s disease (AD) using plasma tau phosphorylated at threonine 181 (p-tau181), cerebrospinal fluid (CSF) p-tau181, and AV1451 positron emission tomography (PET). METHODS: In the Alzheimer’s Disease Neuroimaging Initiative,...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Yu, Huang, Yu-Yuan, Shen, Xue-Ning, Chen, Shi-Dong, Hu, Hao, Wang, Zuo-Teng, Tan, Lan, Yu, Jin-Tai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094494/
https://www.ncbi.nlm.nih.gov/pubmed/33947453
http://dx.doi.org/10.1186/s13195-021-00834-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094494/
https://www.ncbi.nlm.nih.gov/pubmed/33947453
http://dx.doi.org/10.1186/s13195-021-00834-3

Ejemplares similares